GOLM1 and type 1 diabetes mellitus: In human tissues, analysis of scRNA-Seq data in the Human Pancreas Analysis Program (HPAP) showed that GOLM1 mRNA increases in both quantity and in the proportion of β cells in individuals with single- (n = 8 donors) and double-autoantibody (n = 2 donors) positivity and with T1D (n = 9 donors) compared with nondiabetic controls (n = 15 donors) (Figure 5G), suggesting that “surviving” β cells have more GOLM1 mRNA.